Cerebral Palsy: When a Damaged Brain Leaves a Lasting Mark

The brain injury comes first. Cerebral palsy follows. That distinction matters enormously, as CP is not itself a wound, but rather the permanent shadow one leaves behind.

The NIH’s National Institute of Neurological Disorders and Stroke guidance, reviewed as recently as March 13, 2026, describes CP as a disorder “caused by changes in the developing brain that disrupt its ability to control movement and maintain posture and balance.” The damage happens; CP is an outcome that the victim must live with in the future.

For most, the injury strikes before they ever draw a first breath. Oxygen deprivation during delivery, bleeding in the brain, or destruction of the delicate white matter surrounding a premature infant’s ventricles collectively account for roughly 80–90% of all cases. The CDC, in a February 2026 update, puts the scale in stark terms: about 1 in every 345 American children has CP, making it the most common childhood motor disability in the country.

Some cases, however, emerge after birth. Meningitis, near-drowning, and traumatic brain injury can all trigger CP, but only during the critical window when the brain is still forming, generally before age five. Once the skull has fully matured, the same injuries are referred to as traumatic brain injuries or acquired brain injuries.

To remedy what many see as the government’s chronic underfunding for CP, Tennessee Rep. Steve Cohen introduced H.R. 2178, Cerebral Palsy Research Program Authorization Act of 2025, on March 18, 2025. As he stated, “Cerebral palsy… is the most prevalent disability that has no designated federal funding for research.” After introduction, the bill was referred to the House Committee on Energy and Commerce. (No further action within the last Congressional session is reported.)

MO Brings Oxygen into TBI Recovery

Missouri has demonstrated remarkable commitment to our veterans with the ratification of SB 664 on July 14, 2025.  The “Veterans Traumatic Brain Injury Treatment and Recovery Act,” was passed with overwhelming support of 33-0 in the Senate and 156-1 in the House. Governor Mike Kehoe signed this groundbreaking legislation on Monday, establishing a fund to reimburse Hyperbaric Oxygen Therapy (HBOT) facilities treating veterans with TBI or PTSD, recognizing the treatment’s potential to combat veteran suicide and opioid addiction. The initiative represents a projected investment exceeding $5 million annually, underscoring the state’s confidence in this therapeutic approach.

HBOT works by delivering 100% oxygen in pressurized chambers at 1.4-3 times normal atmospheric pressure, dramatically increasing oxygen delivery to damaged brain tissues. Advocates report that this treatment “stimulates brain wound healing and can reverse soft tissue and neurocognitive damage” without requiring invasive surgery or pharmaceutical interventions. Patients can “experience recovery of cognitive and neurological functioning” through this non-invasive approach.

Clinical research has yielded encouraging results across multiple studies. For moderate-to-severe TBI cases, several high-quality studies demonstrated statistically significant improvements in consciousness recovery compared to standard care alone. Research has consistently shown better Glasgow Outcome Scale scores and reduced mortality rates in HBOT treatment groups. A comprehensive 2016 review highlighted that “most successes occurred within hours after TBI,” emphasizing the importance of early intervention. Particularly compelling evidence comes from pediatric research, where a study of 56 children with severe TBI found that HBOT “significantly improved quality of life and reduced complications” compared to control groups. Additional research involving 56 patients showed “significant improvement in symptoms and increased brain activity” measurable through SPECT (Single Photon Emission Computed Tomography) brain imaging.

The treatment maintains a generally acceptable safety profile, with most side effects being minor and temporary, including ear discomfort, headaches, and fatigue. Serious adverse events remain rare when HBOT is properly administered. This positive safety record, combined with growing clinical evidence and strong legislative support, has led some VA facilities to begin offering HBOT treatment to veterans, representing an important step toward broader acceptance of this promising therapeutic intervention.